OEL Fastrac catalog listing now available as a RSS feed

Affygility Solutions is pleased to announce that its OEL Fastrac catalog listing is now available as a RSS (Really Simple Syndication) feed. Listed below is an example of the feed displaying that latest six occupational exposure limit (OEL) with ADE monographs. Click on the compound name heading to go directly to the specific OEL/ADE monograph product page.

  • Ethyl Carbamate


    Ethyl carbamate (urethane) was used in medicine as a hypnotic agent, anesthetic agent and antineoplastic agent, is used as an intermediate in the synthesis of a number of chemicals, as a solubilizer, as a co-solvent for pesticides and fumigants, and occurs naturally in foods and beverages, especially alcoholic beverages.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Ethyl Carbamate is available for purchase for $639 USD.

  • Panobinostat Lactate


    Panobinostat lactate is indicated in the treatment of patients with relapsed and/or refractory multiple myeloma in combination with dexamethasone and bortezomib in patients who have received at least two (2) previous treatment regimens including bortezomib and an immunomodulatory agent. Panobinostat lactate is a hydroxamic acid analog histone deacetylase (HDAC) inhibitor that prevents the enzymatic activity of HDACs at nanomolar concentrations. Histone deacetylase enzymes target lysine groups on histones and various non-histone proteins such as p53 atubulin, heat shock protein 90 (HSP90) and HIF-la.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Panobinostat Lactate is available for purchase for $639 USD.

  • Cobicistat


    Cobicistat is a cytochrome P450 3A (CYP3A) inhibitor indicated to increase systemic exposure of atazanavir or darunavir, as a once daily dosing regimen, in combination with other antiretroviral (ARV) agents in the treatment of HIV-1 infection. Boosting systemic exposure of ARVs while minimizing dosage allows for better treatment outcomes and a decreased side effect profile. Cobicistat is a mechanism-based inhibitor that acts as a pharmacokinetic enhancer by inhibiting CYP3A isoforms. Inhibition of CYP3A-mediated metabolism by cobicistat increases the systemic exposure of CYP3A substrates atazanavir and darunavir; therefore, enabling increased anti-viral activity at a lower dosage. Cobicistat does not have any anti-HIV activity on its own.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Cobicistat is available for purchase for $639 USD.

  • Fluphenazine Decanoate


    <Fluphenazine decanoate is a decanoate ester of fluphenazine, trifluoromethyl phenothiazine derivative, intended for the management of schizophrenia (2, 3, 4, 5). Its basic effects are considered to be no different than fluphenazine, except for its duration of action.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Fluphenazine Decanoate is available for purchase for $639 USD.

  • Prilocaine


    Prilocaine is an amide-type local anesthetic, pharmacologically similar to lidocaine, that is administered by topical application and as Infiltration or nerve block anesthesia in dental procedures.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Prilocaine is available for purchase for $639 USD.

  • Tiopronin


    Tiopronin is indicated for prevention of kidney stones, has been evaluated for the treatment of arthritis. Tiopronin complexes with cysteine to prevent cysteine stone formation.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Tiopronin is available for purchase for $639 USD.

If you wish to add the feed to a feed reader, here’s the link: http://affygility.com/oel/feed.xml


mm

About Dean Calhoun

view all posts

Dean is the President and CEO of Affygility Solutions. Affygility Solutions provides environmental, health and safety software, potent compound safety, industrial hygiene, containment validation services to the pharmaceutical, biotechnology, and medical device industry. "Dean's Google+ Profile"

Affygility Solutions - provider of potent compound safety, webinars, and compliance management software